Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 03 Feb 2026 | Mirzha De Manuel Cabinet member | Implementation of the EU pay transparency directive | SRC |
| 03 Feb 2026 | Mirzha De Manuel Cabinet member | Implementation of the EU pay transparency directive | — |
| 16 Jan 2026 | Ioana Diaconescu Head of Unit | Johnson & Johnson requested this meeting to engage with DG TAXUD regarding the simplification agenda in the field of direct taxation. | — |
| 16 Jan 2026 | Ioana Diaconescu Head of Unit | Johnson & Johnson requested this meeting to engage with DG TAXUD regarding the simplification agenda in the field of direct taxation. | SRC |
| 03 Dec 2025 | Ulla Schwager Head of Unit | Exchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sector | — |
| 03 Dec 2025 | Ulla Schwager Head of Unit | Exchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sector | SRC |
| 01 Dec 2025 | Jana Dabbelt Cabinet member | Digital and AI as an enabler in healthcare | — |
| 01 Dec 2025 | Patricia Reilly Cabinet member | Competitiveness and sustainable healthcare | — |
| 01 Dec 2025 | Jana Dabbelt Cabinet member | Digital and AI as an enabler in healthcare | SRC |
| 01 Dec 2025 | Patricia Reilly Cabinet member | Competitiveness and sustainable healthcare | SRC |
| 28 Oct 2025 | Maroš Šefčovič Commissioner | Priorities of the EU’s trade agenda | SRC |
| 28 Oct 2025 | Maroš Šefčovič Commissioner | Priorities of the EU’s trade agenda | — |
| 17 Oct 2025 | Chiara Galiffa Cabinet member | EU – US relations | SRC |
| 17 Oct 2025 | Bernd Biervert Cabinet member | EU – US relations | SRC |
| 17 Oct 2025 | Bernd Biervert Cabinet member | EU – US relations | — |
| 25 Sept 2025 | Chiara Galiffa Cabinet member | EU – US relations | — |
| 25 Sept 2025 | Chiara Galiffa Cabinet member | EU – US relations | SRC |
| 03 Jun 2025 | Kilian Gross Head of Unit | Exchange of views on application of the AI Act to the healthcare sector. | — |
| 03 Jun 2025 | Kilian Gross Head of Unit | Exchange of views on application of the AI Act to the healthcare sector. | SRC |
| 04 Apr 2025 | Maurice Whelan Head of Unit | Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation | — |
| 04 Apr 2025 | Maurice Whelan Head of Unit | Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation | SRC |
| 04 Apr 2025 | Tobias Wiesenthal Head of Unit | Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation | SRC |
| 04 Apr 2025 | Tobias Wiesenthal Head of Unit | Scientific roundtable discussion between the European Commission’s Joint Research Centre and the pharmaceutical industry on the topic of leveraging health data and data sciences for innovation | — |
| 25 Mar 2025 | Roberto Viola Director-General | Discussion on Artificial Intelligence (AI), MedTech technologies and digital health | SRC |
| 25 Mar 2025 | Roberto Viola Director-General | Discussion on Artificial Intelligence (AI), MedTech technologies and digital health | — |
Mission & Goals
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.
EU Legislative Interests
Prevention and lifestyle, REACH, Medical devices legislation, In-Vitro Diagnostics, Clinical Trials, Falsified Medicines, Transparency legislations, chemicals, environmental initiatives, climate change, research, competitiveness of industrial sectors, IMI2, Trade & Tariffs, Taxation, Digital, EU Pharmaceuticals Legislation.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EFPIA, MedTech Europe, AmCham EU/BE, EBE, EVM, COCIR, Euromcontact, EJF, CSR Europe, EASSI, NIA, EPC Global, EPC, EPAA, Digital Europe, Europen, BusinessEurope
Organisation Members
as company, we do not have members
Connected Legislation